Sprague John M 4/A
4/A · T2 Biosystems, Inc. · Filed Mar 29, 2022
Insider Transaction Report
Form 4/AAmended
Transactions
- Exercise/Conversion
Common Stock
2022-02-21+10,000→ 55,414 total - Award
Restricted Stock Units
2022-02-20+600,000→ 600,000 total→ Common Stock (600,000 underlying) - Tax Payment
Common Stock
2022-02-21$0.47/sh−3,775$1,759→ 51,639 total - Exercise/Conversion
Restricted Stock Units
2022-02-21−10,000→ 0 total→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 3,968 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2021 and 5,961 shares acquired under the ESPP on November 15, 2021.
- [F3]3,775 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F4]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 138,775.
- [F5]On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal installments commencing on February 20, 2023.
- [F6]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.